BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9587679)

  • 1. Interferon therapy of hematologic malignancies.
    Foon KA
    Cancer Treat Res; 1998; 94():1-21. PubMed ID: 9587679
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of interferon in patients with hairy cell leukemia and myeloproliferative disorders].
    Skotnicki AB; Wolska-Smoleń T
    Acta Haematol Pol; 1994; 25(2 Suppl 1):124-35. PubMed ID: 8067197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Interferon in hematological malignancies.
    Giles FJ; Ozer H
    Curr Opin Biotechnol; 1991 Dec; 2(6):847-50. PubMed ID: 1367959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hematologic diseases with alpha interferon].
    Castaigne S
    Bull Cancer; 1988; 75(9):859-62. PubMed ID: 3207895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon-alpha in therapy of malignant hemoblastoses].
    Schuler M; Aulitzky WE; Schneller F; Peschel C; Huber C
    Internist (Berl); 1995 Dec; 36(12):1133-8. PubMed ID: 8567218
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferon alfa-2a.
    Williams CD; Linch DC
    Br J Hosp Med; 1997 May 7-20; 57(9):436-9. PubMed ID: 9274677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon-alpha in the treatment of chronic myeloid leukemia].
    Guilhot F
    Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukemia and myelomatosis.
    Catovsky D
    Cancer Chemother Biol Response Modif; 1987; 9():134-64. PubMed ID: 3079401
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
    Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
    Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of myelogenous leukemia: current status and investigational options.
    Kantarjian HM; O'Brien S; Anderlini P; Talpaz M
    Blood; 1996 Apr; 87(8):3069-81. PubMed ID: 8605319
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted therapy for hematologic malignancies.
    Kuriakose P
    Cancer Control; 2005 Apr; 12(2):82-90. PubMed ID: 15855891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
    Boqué C; Grañena A
    Sangre (Barc); 1998 Apr; 43(2):155-63. PubMed ID: 9656777
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia.
    Baer MR; Ozer H; Foon KA
    Br J Haematol; 1992 Jun; 81(2):167-9. PubMed ID: 1643013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cytogenetic and fluorescence in situ hybridization evaluation of interferon-alpha in the treatment of chronic myeloid leukemia.
    Itoh T; Tamura S; Takemoto Y; Kakishita E
    Int J Mol Med; 1999 Dec; 4(6):659-63. PubMed ID: 10567680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myelogenous leukemia--update and future directions.
    Kantarjian HM; Deisseroth A; Talpaz M
    Rev Invest Clin; 1994 Apr; Suppl():118-24. PubMed ID: 7886295
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer Center.
    Kantarjian HM; Talpaz M
    Leuk Lymphoma; 1993; 11 Suppl 1():169-74. PubMed ID: 8251891
    [No Abstract]   [Full Text] [Related]  

  • 17. Hematopoietic stem cell transplantation in hematologic malignancy.
    Archuleta TD; Devetten MP; Armitage JO
    Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer immunotherapy: the interferon-alpha experience.
    Kirkwood J
    Semin Oncol; 2002 Jun; 29(3 Suppl 7):18-26. PubMed ID: 12068384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complete cytogenetic remission of chronic myeloid leukemia with low-dose interferon alfa-2b and monthly high-dose busulfan].
    Armenta D; Espallargas C; Paz A; Rodríguez Martorel J; Ladines R; Alvarez C; Román J; Andrés P
    Sangre (Barc); 1996 Dec; 41(6):465-7. PubMed ID: 9148424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemias and myeloma.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 1988; 10():129-47. PubMed ID: 3079381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.